¦Ï°¦»É¤¤¬r

«e¨¥

        ¦³Ãö¥xÆW¤û¦Ïµ¥¤Ï¯ìÃ~»É¤¤¬rªº¯f¨Ò³ø§i±q¥¼¦b¤åÄm¤W³ø§i¹L¡A¤]¥¼¦bÃ~Âå¾Ç·|¡B°Q½×·|©Î¨ä¥L¤½¶}³õ¦X³Q´£¥X°Q½×¡C¤Ï¯ìÃ~ªº»É¤¤¬r¦b¥xÆW¦ü¥G¬O¤£­«­n¡A¦ý¨Æ¹ê¨Ã«D¦p¦¹¡A¥»¯f©Ò¥H¥¼³Q´£¥X°Q½×¥i¯àªº¦]¯À¦³¡G1. ¹}¾i¹A¤á¡A²{¦bÃ~Âå¤Î¦³Ãö¸ÕÅç¬ã¨s¾÷ºc¹ï¥»¯f¤£¤F¸Ñ¡C2. ¥»¯f±`§e°¸µo©Ê¡BºC©Ê¯fµ{¡BÁ{§É¤Wªº¯f¼x»P³\¦h¨ä¥L¯f¬ÛÃþ¦ü©Î¨ä¥L¯e¯f²V¦X·P¬V¦Ó³Q©¿µø¡C

        ¥»¯f¦b¦Ï°¦ªºµo¥Í²v¥Hºø¦Ï¥e­º¦ì¡A¨ä¦¸¬°¤s¦Ï¡C(Soli and Nafstad 1978)(Soli and Froslie 1977)

¨Ó·½

        ¼QÅx¹LÃľ¯ªº¾ð¸­¡Bªª¯ó(»É¥i±q¤gÄ[¤¤³Q§l¦¬¦Ó²Ö¿n¹F200ppmªº¿@«×)¡B¯ç­¹¤ÑµMÆQ¡A­¹¤J§t»É²K¥[¾¯¡B¦ì©ó§M·Ò¼tªþªñ¦Ó³Q¦Ã¬Vªº«C¯ì®Æ¡B¬y¸g»ÉºÞªº¤ô¡B²¸»Ä»Éªº¼QÅx¡B¥Î²¸»Ä»É¨Ó±þ¦º¦À¶í¤ºªºÄ¦Ãþª«½è¡A©Î¥H§t¦³²¸»Ä»ÉªºÃĪ«¨Ó¬I¦æÃįD¡C²¸»Ä»É¤]¥i·íÅXÂÎÃĦӸg¤fµ¹¤©¡C³o¨Ç¦]¯À³£¦³¥i¯àÅý¦Ï°¦¦]­¹¤J¹L¶qªº»É¦Óµo¥Í¤¤¬r²{¶H¡C

¬r©Ê

        ¦bºø¦Ï¡B²¸»Ä»Éªº¤fªA¤¤¬r¾¯¶q¬°20mg¡þ¤½¤çÅé­«¡C²Éª¬¹}®Æ¸Ì©Ò§tªº»É§Y¥O¤Ö¨ì50ppm¤]¯à¬r®`ºø¦Ï¡C

        ½Þ¡B¹ï»Éªº§Ô¨ü©Ê¸û°ª¡A¤@¯ë¹}®Æ¤¤³£§t¦³²¸»Ä»É¡A¥i¥H«P¶i½Þ°¦ªº¥Íªø¡C¦ý¤fªA250~400ppmªº»É¥i¯à·|¤¤¬r¡A¤@¯ë»{¬°1000ppm·|­P¦º¡C

        »É¬r©Ê¨ü°Êª«¦~Ä֤Ϋ~ºØ¨â¤j¦]¯À¼vÅT¡A¦¹¥~°Êª«ªºÀç¾i¤£¨}¡B¸T­¹ºò­¢ª¬ºA¡A໯ʥF¤Î¨xŦ¨ü¶Ë®`µ¥¦]¯À¤]·|¼vÅT»É¹ï°Êª«¥»¨­ªº¬r©Ê¡C(­°§C°Êª«¹ï»Éªº­@¨ü©Ê)

§@¥Î¾÷§Ç

        1. ¹ï¨xŦ¦Ó¨¥¡G

        »É¡÷ ¨xŦ¶J¦s¹L¶q¡÷·|§í¨î¨xŦ¦UºØ°ò¥»¥NÁÂú@ªº§@¥Î¡÷µo¥Í¨x¥\¯à»Ùê¡÷³y¦¨¨x²Ó­MÃa¦º¡C

        ¦¹®É¡ASGOT(¦å²M¾¢®ò¯ó¾L»ÄÂà®òú@)¡BLDH(¨Å»Ä¥h²Bú@)¡Bplasma arginase(¦å¼ßªü°ò®ò°òú@)¡Bplasma bilirubin(¦å¼ßÁx¬õ½è)µ¥³£·|¤W¤É¡A¦Ó¨x¥\¯à·|­°§C¡C(Buckµ¥1973)

        2. ¦å²G¤¤

        »É¡÷¥Ñ¨xŦÄÀ©ñ¤J¦å²G¤¤¡÷¶i¤JRBC¤º¡÷Cu2+·|±N¥¿±`ªºFe2+¦å¬õ¯ÀÂà¤Æ¦¨Åܩʦå¬õ¯À¡C

        ¦¹¥~¡A¬õ¦å²y¾¢®ò°ò²¸(GSH)ªº¿@«×·|¤U­°Cu2+³QÁ٭즨Cu+¡ACu+·|©MGSHµ²¦X¨Ï GSH¿@«×¤U­°¡A¬õ¦å²y«Ü®e©ö¯}¸H(©Mº¯³zÀ£¦³Ãö)¡C(Thompson and Todd 1974)

        3. ¹ïµÇŦªº§@¥Î

        »É¡÷³y¦¨hemolytic crisis(·»¦å¦M¶H)¡÷¨ÏµÇ¤pºÞ¤Îµ·²yÅéÃa¦º¡÷µÇ°IºÜ¡C(Gopinath 1974)

Á{§É¯gª¬¤Î¯fÅÜ

        ¯gª¬¡G¯f¯b§e²{°I®z¡B¹½­¹¡B¦å¬õ¬r§¿¡B¶À¯n¡B©I§l§xÃø¥H¤Î¥ð§Jµ¥¯gª¬¡C

        ¯fÅÜ¡G¥D­n¯fÅܦb¨x¡BµÇ»P»H¯Ö¡A¨ä¥LŦ¾¹µLÅãµÛ¯fÅÜ¡C

        ¨x¡G§e¸~¤j¡BIJ·P°í¹ê¡Bªí­±¦³«Ü¦h¤pµ²¸`¡C

        Ãè¤U¡G¨x²Ó­Mªº²Ó­M½è§t¦³¤j¤p¡B§Îª¬¤Î¼Æ¥Ø¤£¤@ªºªÅ­M¡A¨x²Ó­MÅܵȤj¡C

        ¦b»Éªº¯S®í¬V¦â¤Á¤ù¤W¡A»ÉÁû²É§e¶Â½Å¦â¡B¤j¤p§Îª¬¤£¤@¡A¦s©ó¨x²Ó­M¤ºªº»ÉÁû²É¥D­n¤À§G¦b¾aªñÁx¤pºÞ¨º¤@°¼ªº²Ó­M½è¤º¡C

        µÇ¡GÂù°¼µÇŦ§e§¡¤Ã¸~µÈ¡B·t¬õ¦â¡Aªí­±¥­·Æ¡C

        Ãè¤U¡GµÇ¤pºÞ¤W¥Ö²Ó­Mµo¥ÍHyaline droplet degeneration¤ÎµÇ¤pºÞµÄ¤º¦³Hemoglobin casts¡C

        ¦b»ÉÁû²Éªº¯S®í¬V¦â¤Á¤ù¤W¡A»ÉÁû²É¦s¦b©óµÇªñ°¼¦±¤pºÞ¤W¥Ö²Ó­M¤§²Ó­M½è¤º¡C

¹w¨¾»PªvÀø

        ¹w¨¾¡G

        1. ºø¦Ï50~500mg¡þday໻ĻÏ(¤fªA)©M0.3~1gªº²¸»Ä¶u¡A(³s¥Î)¤T¶g¢w ¢w¥i¥­¿Å¹L¶qªº»É¡A¨¾¤î»É»W¿n¦b¨xŦ¤º¡C

        2. ໬I¥Î¦bªª¯ó¦a¤W¢w ¢w¥i¥­¿Å»Éªº§t¶q¡C

        ªvÀø¡G

        1. BAL¢w ¢w¬°§t¦³Âù²¸¾JªºÃɧΪ«½è¡C

        §@¥Î¡G

        BAL¥i©MCu+µ²¦X¡A¦A¥Ñ§¿±Æ¥XÅé¥~¡A¥i¨¾¤îGSHªº¤U­°¡C(Clarke and Clarke 1967)

¹}®ÆÀç¾iÂø»x(p.101¡ã104)¢w³¯«\§Ê¡B¤E¥|¦~²Ä¤»´Á